
Welcome to MIRCERA®
MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).
Mircera: Uses, Taking, Side Effects, Warnings - Medicine.com
What is Mircera? Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called erythropoietin to …
Mircera (methoxy polyethylene glycol-epoetin beta) - Uses, Side ... - WebMD
Jan 30, 2025 · Mircera is an injection that may be given under your skin by either you, your caregiver, or your health care provider. What is Mircera used for? Mircera (methoxy polyethylene glycol - epoetin...
Mircera (Methoxy Polyethylene glycol-epoetin beta): Side ... - RxList
Oct 17, 2024 · Mircera (Methoxy Polyethylene glycol-epoetin beta) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison …
MIRCERA®
What is MIRCERA ®? MIRCERA ® is a Continuous Erythropoetin Receptor Activator (C.E.R.A.) indicated for: the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in …
Mircera: Uses, Side Effects, Alternatives & More - GoodRx
Sep 10, 2023 · Mircera is a medication that's used to treat anemia (low red blood cells) in people who have kidney problems. It's approved for people age 5 years and older who are on dialysis, though it …
Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more deaths among...
Mircera Injection: Uses, Dosing, Warnings & Side Effects - Drugs.com
Jun 26, 2024 · Mircera is a man-made form of a protein normally produced by the kidneys that helps your body produce red blood cells. When your body does not make enough of this protein because …
DailyMed - MIRCERA- methoxy polyethylene glycol-epoetin beta …
Jun 5, 2024 · Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more …
MIRCERA is indicated for the treatment of anaemia associated with chronic kidney disease (CKD). Adult patients on dialysis and adult patients not on dialysis.